Reply to: "COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated".
J Am Acad Dermatol
; 87(1): e47-e48, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-1763788
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Rheumatic Diseases
/
Antirheumatic Agents
/
Rituximab
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Am Acad Dermatol
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS